| Name | Title | Contact Details |
|---|---|---|
John Northcott |
Chief Commercial Officer | Profile |
Andrew Sargent |
Senior Director, IT R&D and Clinical Systems | Profile |
Jing Tao |
Director, Formulation R&D | Profile |
Roy Haskell |
Executive Director, Formulation R&D | Profile |
John Houston |
President of R&D | Profile |
Opexa Therapeutics is a Spring, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
EMD Serono is the North America biopharma business of Merck KGaA, Darmstadt, Germany, employing over 1,200 individuals around the country with U.S. headquarters located in Rockland, Massachusetts. The company develops and offers therapies for specialty-care conditions, like multiple sclerosis, infertility and cancer. EMD Serono is committed to transforming lives by developing therapies that patients need and providing industry-leading educational and support programs.
Morphogenesis is a clinical stage company developing novel cell and gene therapies based on distinct and synergistic technology platforms. Our mission is to change the way chronic diseases are treated by engaging the innate intelligence of the body.
Synsorb Biotech Inc. is a Calgary, AB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Tarcine is a Thousand Oaks, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.